Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
52 week low
|
Expensive Underperformer
441.9500
-6.00
(
-1.34
%)
NSE
Jan 14, 2026
15:31 PM
New 52W Low today
Volume:
329.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
29 Feb 2024
52 week low
441.95
-1.34%
SUVEN PHARMACEUTICALS LIMITED
Sell:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 571
Recommendation
Target
Geojit BNP Paribas
Cohance Lifesciences Ltd. is trading below all available SMAs
More from Cohance Lifesciences Ltd.
Recommended
Nifty 50 outlook: Hopes rise for 2026 after a volatile year
The Baseline |
15 Jan 2026, 01:13PM
The top five: Analysts pick their winners for Q3
The Baseline |
15 Jan 2026, 11:06AM
Market closes lower, amid foreign fund outflows & US tariff threats on Iranian trading partners
Trendlyne Marketwatch |
14 Jan 2026, 04:03PM